2016•PubMedRequires access

Hyponatremia in cirrhosis: Risk factors and prognostic value.

Rym Ennaifer, Myriam Cheikh, Hayfa Romdhane, Rafika El Elj, Houda Ben Nejma, Wassila Bougassas, Najet Bel Hadj

Open publisher page 8 citations

Abstract

Background Hyponatremia is the most common electrolyte abnormality encountered in cirrhotic patients. Recent studies have shown that hyponatremia was correlated with severity of cirrhosis and associated with increased risk of complications and mortality. However this relationship is still unclear. The aims of the present study were to search predictive factors for hyponatremia in cirrhosis and to assess its prognostic value. Methods We performed a retrospective study, including consecutive cirrhotic patients admitted to our department between January 2011 and April 2014. Patients and cirrhosis characteristics were studied. Serum sodium levels were determined at admission. The cutoff level of 130 mmol/l was chosen because it is widely accepted to define hyponatremia in patients with cirrhosis. Predictive factors of hyponatremia development and its impact on the outcome (cirrhosis complications and survival) were evaluated. Results We included 143 cirrhotic patients: 67 females (46.9%) and 76 males (53.1%) with a mean age of 58 years. Etiology of cirrhosis was mainly viral (56.7%). Child-Pugh stage was B in 41.2% and C in 25.9%. Mean MELD score was 15 [6-40]. The prevalence of dilutional hyponatremia as defined by a serum sodium concentration ≤130 mmol/L or ≤135 mmol/L was 10.5% and 31.4% respectively. Serum sodium level ≤130 mmol/L was strongly associated with severity of liver function impairment as indicated by Child-Pugh C (OR=7.84;p<0.001), and MELD score> 16 (OR=6.76; p=0.001). Survival without complications was reduced in patients with hyponatremia but was only significant if a serum sodium concentration ≤135 mmol/L was considered (p=0.012). Survival without hepatic encephalopathy and without hepatorenal syndrome was significantly reduced in patients with hyponatremia (p<0.001 for both). Global survival was also reduced in patients with hyponatremia at 1 year: 22.5% versus 68.7%, as well as mean global survival: 8.3 versus 32.8 months (p<0.0001). Conclusion Low serum sodium level was correlated with severity of cirrhosis. Hyponatremia was a negative prognostic factor associated with increased short-term morbi-mortality.

About this research paper

What this paper is about

Background Hyponatremia is the most common electrolyte abnormality encountered in cirrhotic patients. Recent studies have shown that hyponatremia was correlated with severity of cirrhosis and associated with increased risk of complications and mortality. However this relationship is still unclear. The aims of the present study were to search predictive factors for hyponatremia in cirrhosis and to assess its prognostic value. Methods We performed a retrospective study, including consecutive cirrhotic patients admitted to our department between January 2011 and April 2014. Patients and cirrhosis characteristics were studied. Serum sodium levels were determined at admission. The cutoff level of 130 mmol/l was chosen because it is widely accepted to define hyponatremia in patients with cirrhosis. Predictive factors of hyponatremia development and its impact on the outcome (cirrhosis complications and survival) were evaluated. Results We included 143 cirrhotic patients: 67 females (46.9%) and 76 males (53.1%) with a mean age of 58 years. Etiology of cirrhosis was mainly viral (56.7%). Child-Pugh stage was B in 41.2% and C in 25.9%. Mean MELD score was 15 [6-40]. The prevalence of dilutional hyponatremia as defined by a serum sodium concentration ≤130 mmol/L or ≤135 mmol/L was 10.5% and 31.4% respectively. Serum sodium level ≤130 mmol/L was strongly associated with severity of liver function impairment as indicated by Child-Pugh C (OR=7.84;p<0.001), and MELD score> 16 (OR=6.76; p=0.001). Survival without complications was reduced in patients with hyponatremia but was only significant if a serum sodium concentration ≤135 mmol/L was considered (p=0.012). Survival without hepatic encephalopathy and without hepatorenal syndrome was significantly reduced in patients with hyponatremia (p<0.001 for both). Global survival was also reduced in patients with hyponatremia at 1 year: 22.5% versus 68.7%, as well as mean global survival: 8.3 versus 32.8 months (p<0.0001). Conclusion Low serum sodium level was correlated with severity of cirrhosis. Hyponatremia was a negative prognostic factor associated with increased short-term morbi-mortality.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Background Hyponatremia is the most common electrolyte abnormality encountered in cirrhotic patients. Recent studies have shown that hyponatremia was correlated with severity of cirrhosis and associated with increased risk of complications and mortality. However this relationship is still unclear. The aims of the present study were to search predictive factors for hyponatremia in cirrhosis and to assess its prognostic value. Methods We performed a retrospective study, including consecutive cirrhotic patients admitted to our department between January 2011 and April 2014. Patients and cirrhosis characteristics were studied. Serum sodium levels were determined at admission. The cutoff level of 130 mmol/l was chosen because it is widely accepted to define hyponatremia in patients with cirrhosis. Predictive factors of hyponatremia development and its impact on the outcome (cirrhosis complications and survival) were evaluated. Results We included 143 cirrhotic patients: 67 females (46.9%) and 76 males (53.1%) with a mean age of 58 years. Etiology of cirrhosis was mainly viral (56.7%). Child-Pugh stage was B in 41.2% and C in 25.9%. Mean MELD score was 15 [6-40]. The prevalence of dilutional hyponatremia as defined by a serum sodium concentration ≤130 mmol/L or ≤135 mmol/L was 10.5% and 31.4% respectively. Serum sodium level ≤130 mmol/L was strongly associated with severity of liver function impairment as indicated by Child-Pugh C (OR=7.84;p<0.001), and MELD score> 16 (OR=6.76; p=0.001). Survival without complications was reduced in patients with hyponatremia but was only significant if a serum sodium concentration ≤135 mmol/L was considered (p=0.012). Survival without hepatic encephalopathy and without hepatorenal syndrome was significantly reduced in patients with hyponatremia (p<0.001 for both). Global survival was also reduced in patients with hyponatremia at 1 year: 22.5% versus 68.7%, as well as mean global survival: 8.3 versus 32.8 months (p<0.0001). Conclusion Low serum sodium level was correlated with severity of cirrhosis. Hyponatremia was a negative prognostic factor associated with increased short-term morbi-mortality.

Key concepts: Hyponatremia, Cirrhosis, Medicine, Gastroenterology, Internal medicine, Etiology, Retrospective cohort study

Related papers

Back to paper searchBrowse research topicsOriginal source
Hyponatremia in cirrhosis: Risk factors and prognostic value. — Research Paper | ScholarLens